SAM.gov75A50126R00002
Open
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
- Response deadline
- Jul 30, 2026 Closed
- Date posted
- Jul 8, 2026
- Source
- Open notice
Description
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Classifications
Documents (2)
- 75A50126R00002 Amend 0001.pdf.pdf1.6 MBNot yet available
- 06 RFP_PBS_2PAM_2026_Final.pdf.pdf1.5 MBNot yet available
Contacts
Similar contracts
- Strand-Specific RNA-Sequencing ServicesMADue Sep 10, 2026
- Trusted Partner Program Coming Soon - UpdateNorth Carolina
- Custom Inducible Knockin MouseMarylandDue Sep 1, 2026
- Intent to Sole Source - Duke University MRI ServiceDue Aug 31, 2026
- Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo ValidationDue Sep 10, 2026
- Notice of Intent to Sole Source - Gut Microbiome DNA Sequencing ServicesPennsylvaniaDue Sep 1, 2026